1. Evolocumab use and LDL-C lowering in a cohort of European patients with familial hypercholesterolemia (FH) - results from the Heymans study. (August 2021) Authors: Sibartie, M.; Dhalwani, N.; Ebenbichler, C.; Filardi, P. Perrone; Bruckert, E. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗